Manufacturer
Aurobindo Pharma Limited (Unit III),
Contents
Lamivudine
Indication
HIV infection.
Instruction
May be taken with or without food.
Drug interaction
Increased hepatic decompensation w/ interferon alfa. May increase the adverse effects of emtricitabine or emtricitabine-containing products. Bioavailability may decrease w/ methadone. Co-trimoxazole may increase the serum levels of lamivudine. Ribavirin may increase the risk of hepatotoxicity.